Exact Sciences Corp
(NAS:EXAS)
$
54.21
-0.51 (-0.93%)
Market Cap: 10.03 Bil
Enterprise Value: 11.77 Bil
PE Ratio: 0
PB Ratio: 3.12
GF Score: 80/100 Exact Sciences Corp at Piper Sandler Healthcare Conference Transcript
Nov 30, 2022 / 09:30PM GMT
Release Date Price:
$44.95
(+9.13%)
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
All right. Thank you, everyone, for joining us. Thank you, Kevin. I'm here with Kevin Conroy, Exact Sciences' CEO. I'm just going to jump right into the Q&A.
Questions & Answers
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
So Q3, you're firing on all cylinders. Honestly, I could say that was the most cleanest quarter of all of my cover -- 20 covered companies. Cologuard worked, Oncotype worked, cost reductions are on track. What exactly was -- happened in the quarter that all things just kind of came together at once? And was it just some kind of motivation? Was there any competitive motivation considering there is a talked about event that's coming up?
Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO
No, it had nothing to do with any competitive dynamic. What -- it had everything to do with the investments that
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot